Urologic oncologyHumansMaleHydroxymethylglutaryl-CoA Reductase InhibitorsProstatic NeoplasmsAged
Understanding the role of statin use on advanced prostate cancer outcomes: Does the statin type, cumulative dose, or duration impact survival?
Alexa Rose León, Michael Risk, William A Ricke, Jinn-Ing Liou, David F Jarrard, Kyle A Richards
Published: 202610.1016/j.urolonc.2025.11.004
Abstract
OBJECTIVE: To further investigate the association of improved survival in men with prostate cancer (PCa) on androgen deprivation therapy (ADT), we hypothesized that increased duration and dose of statin in men with PCa on ADT would show a greater eff…
Preview only. Read the full abstract at the source